DAVID NUTT, PhD is Professor of Neuropsychopharmacology at the Imperial College London, UK. Recorded at the Interdisciplinary Conference on Psychedelic Research David Nutt (ICPR) 2022, in Haarlem, The Netherlands.

https://www.icpr-conference.com/
https://drugreporter.net

Questions: 0:00 Intro 0:05 What will be the heritage of this psychedelic renaissance? 2:26 Can the pharmaceutical industry use psychedelics as modern medicines? 4:23 Can we separate the hallucinogenic effects of psychedelics from the medical benefits? 6:44 What's your view on microdosing? 7:59 How do psychedelics, such as psilocybin compare to traditional antidepressants in treating depression? 10:30 What about Ketamine? How does it compare to psilocybin, how does it affect the brain, and how does it treat depression? 13:05 Can these substances be used outside of their traditional contexts, as modern medicines? 14:52 How do you see the future of psychedelics? What role will they play in mainstream mental health care? 16:10 How can we overcome the scepticism of the general public and scientists, regarding psychedelics?

Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/